Personalized support along your treatment journey

Olumiant Together is a support program that gives you access to the Companion in Care^™ team—a group of people available to help you with personalized assistance, resources, and support throughout your treatment.

Olumiant Together can help you:

Confirm your insurance coverage
Explore savings options if you are commercially insured
Work with your specialty pharmacy to ensure you get your medicine

Supporting you every step of the way

At the start
The Companion in Care team can answer frequently asked questions about Olumiant, your insurance coverage, and the Olumiant savings program.

Along the way
Olumiant Together can help you get more out of doctor visits and give you resources and information about living with your condition.

Here for you
We're here to lend an ear if you want to talk about Olumiant Together. Please keep in mind that a Companion in Care is not a substitute for your healthcare provider and cannot provide medical or treatment advice.

Enroll now

If you do not qualify for a savings card, you can still enroll in Olumiant Together by calling 1-844-OLUMIANT (1-844-658-6426).

To get your savings card,^* we need your HIPAA authorization to work on your behalf to ensure you're at the right specialty pharmacy and paying as little as $5 or $25 a month.

As a reminder, HIPAA is the Health Insurance Portability and Accountability Act. It provides data privacy and security to protect your medical information.

^*Your Companion in Care provided is not a medical professional. Your doctor is your source for medical advice.

^†Terms and Conditions:
^*Offer good until 12/31/2025 or for up to 36 months from Patient qualification into the program, whichever comes first. Patients must have coverage for Olumiant through their commercial drug insurance and a prescription consistent with FDA approved product labeling to pay as little as $5 for a 30-day supply of Olumiant. Offer subject to a monthly cap of wholesale acquisition cost plus usual and customary pharmacy charges and a separate annual cap of $9,100. Patients must have commercial drug insurance and prescription consistent with FDA-approved product labeling to pay as little as $25 for a 30-day supply of Olumiant. Participation in the $25 program requires submission of a prior authorization (PA). If coverage is denied, an appeal must be submitted prior to 5^th month fill. A new PA and appeal or medical exception (ME) must be submitted every 12 months or as required by Lilly to verify coverage status and potential eligibility for the $5 program. Offer subject to a monthly cap and a separate annual cap. Monthly and annual caps are set at Lilly’s absolute discretion and may be changed by Lilly with or without notice. Participation in the program requires a valid patient HIPAA authorization. Patient is responsible for any applicable taxes, fees, or amounts exceeding monthly or annual caps. This offer is invalid for Patients without commercial drug insurance or whose prescription claims for Olumiant are eligible to be reimbursed, in whole or in part, by any governmental program, including, without limitation, Medicaid, Medicare, Medicare Part D, Medigap, DoD, VA, TRICARE^®/CHAMPUS, or any State Patient or Pharmaceutical Assistance Program. Offer void where prohibited by law and subject to change or discontinue without notice. Card activation is required. Subject to additional terms and conditions, which can be found at olumiant.com/olumiant-together.

Meet your team

Once your doctor prescribes Olumiant, different members of your healthcare team may reach out to help you get started.

Your Companion in Care^*

Coordinates with your doctor's office, your specialty pharmacy, and your insurance, so you don't have to
Works with your insurance to determine specialty pharmacy options
Assists you with enrollment in our savings program, if you're eligible

^*Your Companion in Care does not provide medical advice.

Your specialty pharmacy

Works with your insurance company to get Olumiant approved for you
Contacts you to let you know the cost and to set up delivery of your medication once it is approved

Click here for more information about specialty pharmacy.

Your insurance company

Once your insurance receives a prescription and prior authorization from your doctor, they will:

Determine if Olumiant is covered
Inform your doctor or specialty pharmacy if Olumiant is covered
Let you know how much it may cost

Have you had success with Olumiant? We'd love to hear about it!

Give us a call at 1-844-OLUMIANT (1-844-658-6426).

How can I enroll?

There are 3 easy ways you can get started with Olumiant Together:

Enroll through your doctor’s office
Enroll online here
Call 1-844-OLUMIANT (1-844-658-6426)
Enroll with the Lilly Together^™ App

Once you enroll, what's next?

Watch out for an email and text welcoming you to the program!

A Companion in Care will give you a welcome call to talk about how Olumiant Together can support you and what to expect moving forward. A Companion in Care will also check your insurance coverage before you start treatment.

A Companion in Care will give you a call to be sure you received your first delivery of Olumiant.

To connect with a member of the Companion in Care team any time you have a question or just want to talk, call 1-844-OLUMIANT (1-844-658-6426).

Starting Olumiant may be easier with Olumiant Together.

Enroll now

Discover key support options with the Lilly Together™ app

Download the Lilly Together mobile app to enroll in Olumiant savings and support. The app is a resource to help you on your treatment journey. With the Lilly Together app, you can access savings, use daily symptom tracking to understand your progress over time, and connect with your Companion in Care™ team* with a single click to get support along your treatment journey.

*Your Companion in Care provided is not a medical professional. Your doctor is your source for medical advice.

*Your Companion in Care does not provide medical advice.

SAFETY SUMMARY WITH WARNINGS

WARNINGS -

Olumiant may cause serious side effects, including:

Serious infections, including tuberculosis (TB), shingles, and others caused by bacteria, fungi, or viruses. Some people have died from these infections. Olumiant can make you more likely to get infections or make any infections that you have worse. Your doctor should test for TB before starting Olumiant and watch for TB symptoms during treatment. You should not start Olumiant if you have any kind of infection unless your doctor tells you it is okay. While taking Olumiant, tell your doctor right away if you have symptoms of an infection, such as:
- fever, sweating, or chills
- muscle aches
- cough
- shortness of breath
- blood in phlegm
- weight loss
- warm, red, or painful skin or sores on your body
- diarrhea or stomach pain
- burning with urination or urinating more often than normal
- feeling tired
If you get a serious infection, your doctor may stop Olumiant until your infection is controlled.
Increased risk of death in people 50 years of age or older who have at least 1 heart disease risk factor and are taking a medicine in a class of medicines called JAK inhibitors.
Cancer and immune system problems. Olumiant may increase your risk of lymphoma and other cancers, including skin cancers. People taking a medicine in the class of medicines called JAK inhibitors have a higher risk of certain cancers, including lymphoma and lung cancer, especially if you are a current or past smoker. Follow your doctor’s advice about having your skin checked for skin cancer while taking Olumiant.
Increased risk of major cardiovascular events such as heart attack, stroke or death in people 50 years of age and older who have at least 1 heart disease risk factor and taking a medicine in the class of medicines called JAK inhibitors, especially if you are a current or past smoker. Get emergency help right away if you have any symptoms of a heart attack or stroke while taking Olumiant, including:
- discomfort in the center of your chest that lasts for more than a few minutes, or that goes away and comes back
- severe tightness, pain, pressure, or heaviness in your chest, throat, neck, or jaw
- pain or discomfort in your arms, back, neck, jaw, or stomach
- shortness of breath with or without chest discomfort
- breaking out in a cold sweat
- nausea or vomiting
- feeling lightheaded
- weakness in one part or on one side of your body
- slurred speech
Blood clots in the veins of your legs or lungs, and arteries. This may be life-threatening and cause death. Blood clots in the veins of legs and lungs have happened more often in people who are 50 years of age or older and with at least 1 heart disease risk factor taking a medicine in the class of medicines called JAK inhibitors. Stop taking Olumiant and tell your doctor or get emergency help right away if you have any signs and symptoms of blood clots, including swelling, pain or tenderness in the leg, sudden chest pain, or shortness of breath, while taking Olumiant.
Allergic reactions. While taking Olumiant, if you have symptoms, such as rash (hives), trouble breathing, feeling faint or dizzy, or swelling of your lips, tongue, or throat, stop taking Olumiant and get emergency help right away. Some of these reactions seen in people taking Olumiant were serious.
Tears in the stomach or intestines. This happens most often in people who also take nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, or methotrexate. While taking Olumiant, tell your doctor right away if you have fever and stomach-area pain that does not go away, and a change in bowel habits.
Changes in laboratory test results. Your doctor should do blood tests before and while taking Olumiant. You should not take Olumiant if your white or red blood cell count is too low or your liver tests are too high. Your doctor may pause your treatment with Olumiant because of changes in these test results. Your doctor should also check your cholesterol levels approximately 12 weeks after you start Olumiant and as needed.

Common side effects

The most common side effects of Olumiant in people treated for alopecia areata include:

upper respiratory tract infections (cold or sinus infections)
headache
acne
increased cholesterol levels
increased muscle enzyme levels
urinary tract infection
increased liver enzyme levels
inflammation of hair follicles (folliculitis)

tiredness
lower respiratory tract infections
nausea
genital yeast infection
low red blood cell count (anemia)
low white blood cell count (neutropenia)
stomach-area (abdominal) pain
shingles (herpes zoster)
increased weight

The most common side effects of Olumiant in people treated for rheumatoid arthritis include:

upper respiratory tract infections (cold or sinus infections)
nausea

herpes simplex virus infections, including cold sores
shingles (herpes zoster)

These are not all the possible side effects of Olumiant. Tell your doctor if you have any side effects. You can report side effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch .

Before using

Before you use Olumiant, tell your doctor if you:

Are being treated for an infection, have an infection that won’t go away or keeps coming back, or think you have symptoms of an infection.
Have TB or have been in close contact with someone with TB.
Have had shingles (herpes zoster).
Have had hepatitis B or C, cancer, or blood clots in the veins of your legs or lungs.
Live, have lived, or have visited parts of the country that increase your risk of fungal infections. These may include the Ohio and Mississippi River valleys and the Southwest. Ask your doctor if you do not know if you have lived in an area where these infections are common.
Are a current or past smoker.
Have had a heart attack, other heart problems or stroke.
Have other medical conditions, including kidney or liver problems, low blood cell counts, diabetes, lung disease, HIV, or a weak immune system.
Have any stomach-area pain or have been diagnosed with inflammation in the large intestine (diverticulitis) or ulcers in your stomach or intestines.
Have recently received or plan to receive a vaccine. People taking Olumiant should not receive live vaccines.
Are pregnant or plan to become pregnant. It is not known if Olumiant may harm your unborn baby. If you become pregnant while taking Olumiant, call Eli Lilly and Company at 1-800-545-5979 to report the pregnancy.
Are breastfeeding or plan to breastfeed. You should not breastfeed while taking Olumiant and for 4 days after the last dose. Talk to your doctor about the best way to feed your baby while taking Olumiant.
Are taking other medicines, including prescription and over-the-counter medicines, vitamins, and herbal supplements. It is especially important to tell your doctor, if you take:
- a medicine called probenecid
- medicines that affect your immune system, such biologic medications, other JAK inhibitors, or strong immunosuppressants (such as azathioprine or cyclosporine) since these may increase your risk of infection.
Are under age 18. It is not known if Olumiant is safe and effective in children.

How to take

Take Olumiant exactly as your doctor says.
Take Olumiant once a day by mouth with or without food.
Talk to your doctor if you cannot swallow tablets whole.
If you take too much Olumiant, call your doctor or poison control center at 1-800-222-1222, or go to the nearest hospital emergency room right away.

Learn more

Olumiant is a prescription medicine. For more information, call 1-800-545-5979.

This summary provides basic information about Olumiant but does not include all information known about this medicine. Read the information that comes with your prescription each time your prescription is filled. This information does not take the place of talking with your doctor. Be sure to talk to your doctor or other healthcare provider about Olumiant and how to take it. Your doctor is the best person to help you decide if Olumiant is right for you.

BA CON BS 14SEP2022

Please see full Prescribing Information, including Boxed Warning, and Medication Guide.

INDICATIONS

Olumiant^® (O-loo-me¯ -ant) is a Janus kinase (JAK) inhibitor used to treat:

adults with severe alopecia areata.
adults with moderately to severely active rheumatoid arthritis after treatment with 1 or more medicines called tumor necrosis factor (TNF) blockers have been used, and did not work well enough or could not be tolerated.